Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioma × Watchful Waiting × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 14 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Colonic Neoplasms 4 Papillomavirus Infections 3 Neuroblastoma 3 Lung Neoplasms 3 Brain Neoplasms 3 Anus Neoplasms 3 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Squamous Intraepithelial Lesions 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Liver Neoplasms 2 HIV Infections 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Bile Duct Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Ureteral Neoplasms 1 Thyroid Nodule 1

Interventions

Temozolomide 131 Bevacizumab 62 Radiotherapy 52 Magnetic Resonance Spectroscopy 51 Irinotecan 25 Carboplatin 22 Surgical Procedures, Operative 18 Radiation 18 Specimen Handling 17 Carmustine 17 Nivolumab 15 Biopsy 15 Lomustine 14 Aminolevulinic Acid 14 pembrolizumab 12 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 Cyclophosphamide 10 Topotecan 9 IL13-PE38 9 Everolimus 9 ribociclib 8 fluorodopa F 18 8 dabrafenib 8 X-Rays 8 Imatinib Mesylate 8 Filgrastim 8 Etoposide 8 Erlotinib Hydrochloride 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07025226 2026-01-26

Senolytics

Mayo Clinic

Phase EARLY_PHASE1 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡